The World Health Organization (WHO) considers Pseudomonas aeruginosa a germ requiring urgent action to prevent and control its spread. The bacteria can cause a variety of diseases from chronic lung infections to sepsis. As a result of its increasing resistance to many antibiotics, such infections are often life-threatening. Instead of trying to develop a new antibiotic to combat Pseudomonas aeruginosa, Thomas Böttcher and his team in Konstanz have focused their research efforts on inhibiting virulence factors in the germ. These include toxins and other agents which benefit the infection process. Read more.